4/30/2026CDE Accepts Bayer Filing for FXIa Inhibitor Asundexian in Secondary St...

4/29/2026Insilico Secures China IND Clearance for AI-Discovered IPF Drug Rentos...

4/28/2026Hengrui Launches Large-Scale Phase 3 Trial of GLP-1/GIP Agonist HRS953...

4/28/2026Seven Novel Drug Candidates Win IND Clearance in China Across Modaliti...

4/28/2026Simcere Withdraws and Plans Rapid Resubmission of Rademikibart NDA in ...

4/28/2026Theia Reports Early Clinical Progress for iPSC-Derived Cell Therapy in...

4/23/2026Transcenta Showcases Preclinical Data for LIV1 ADC TST013 at AACR 2026

4/23/20263D Medicines Presents Early Clinical and Preclinical Data for ¹⁷⁷Lu...

4/22/2026Lepu Showcases Dual Oncology Programs at AACR 2026 with Promising Prec...

4/22/2026Hansoh Pharma Reports Positive Mid-Stage Data for Orexin-2 Antagonist ...

4/22/2026GenFleet Unveils FIC KEAP1–NRF2 Molecular Glue GFH603 at AACR 2026

4/22/2026Junshi Unveils Early Clinical and Preclinical Data for Bispecific ADC ...

4/21/2026Immorna Reports Breakthru In Vivo CAR-T Data Showing Deep Lymph Node B...

4/20/2026Junshi Reports Strong Early Activity of PD-1×VEGF Bispecific in MSS C...

4/20/2026Junshi Reports Early High Response Rates for PD-1×VEGF Plus CTLA-4 Co...

4/20/2026Merck to Present First-in-Human Data for China-Origin PD-1/VEGF Bispec...

4/16/2026CSPC Pharma's Tissue Factor ADC SYS6051 Cleared for Clinical Trials in...

4/16/2026Bayer Secures China Approval for Hyrnuo (Sevabertinib) in HER2-Mutant ...

4/16/2026Laekna's Phase 3 AKT Inhibitor Trial Delivers Strong PFS Win in Biomar...

4/16/2026China Drug Regulatory Weekly: Breakthrough Oncology Approvals and Nove...

4/16/2026ArkBio Advances Global Influenza Ambitions as AK0406 Begins First-in-H...

4/15/2026Sirtex's DOORwaY90 Trial Sets New Benchmark in Unresectable HCC With 1...

4/15/2026Shanghai Minwei's Triple Agonist MWN109 Shows Strong Early Weight-Loss...

4/13/2026BioNTech and DualityBio Report Positive Registrational Phase 2 Results...

4/13/2026Innovent Presents Preclinical Oral Data for Tri-Specific Autoimmune T-...

4/13/2026Oculgen Launches Global Phase II/III Trial of OCUL101 in Wet AMD

4/13/2026CanSino Wins China Approval for Three-Component DTcP Combination Vacci...

4/13/2026AstraZeneca's Imjudo Wins China Approval, Likely for First-Line EGFR/A...

4/13/2026BeOne Secures China Conditional Approval for Imdylltra in Third-Line E...

4/10/2026Xuanzhu Expands Global Oncology Reach With Boston Oncology Licensing D...

Page:1/22 Total number of articles:649: [First][<<] [1] [2] [3] [4] [5] [>>] [End]